Markets.com Logo

VIVE

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0001$
  • Previous Close
    0.0001$
  • 52 Week Change
    0.00$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.0001$ - 0.001$
  • Dividend Per Share
    --
  • Market cap
    4 290$
  • EPS
    0
  • Beta
    -53.211
  • Volume
    --

About

VIVE Biotech, Inc. (VIVE.US) is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases, particularly those associated with protein misfolding and aggregation. Their lead product candidate is VVC-801, a small molecule therapeutic designed to reduce the aggregation of misfolded proteins in the brain. The company is currently in the preclinical stage of development, conducting research and studies to advance VVC-801 towards clinical trials. VIVE Biotech operates primarily within the pharmaceutical industry, specifically targeting unmet medical needs in the treatment of diseases like Alzheimer's and Parkinson's.

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Global Debt Crisis Deepens Amidst Iran Conflict and Fiscal Fragility

Ava Grace|--

Apple's Strategic Pivot: MacBook Neo, Supply Chain Tactics, and Foldable Phone Hurdles

Emma Rose|--

Factors

[Company Performance]: Strong financials, revenue growth, and profitability tend to increase stock price; Conversely, poor performance can lead to a decline.

[Industry Trends]: Positive developments in the virtual reality (VR) and metaverse industries, such as increased adoption or technological advancements, can boost investor confidence and drive up the stock price. Conversely, negative industry trends can have the opposite effect.

[Market Sentiment]: General market conditions, investor confidence, and risk appetite significantly influence stock prices. A bullish market usually lifts VIVE.US shares, while a bearish market can drag them down.

[Competition]: The presence and performance of competitors in the VR and technology space affects VIVE.US. Success of competitors or new entrants can pressure VIVE.US, lowering its stock value.

[Regulatory Landscape]: Changes in regulations related to technology, VR, or data privacy can impact investor sentiment. Favorable regulations can positively affect stock price, whereas stricter ones could negatively impact it.

[Technological Innovation]: Breakthroughs in VR technology and product development by VIVE can significantly impact its stock price. Successful products can create enthusiasm, while setbacks or failures can diminish investment.

[Global Events]: Global events, geopolitical instability, or economic crises can create uncertainty, affecting investor sentiment and potentially influencing VIVE.US stock price.

People Also Watch

Latest news

Close Coordination Between Israel and US on Iran Nuclear Talks Highlighted

Noah Lee|--

US-Iran Talks Show Progress Towards Ceasefire Framework Agreement

Liam James|--

Federal Reserve Independence Under Historic Test: Navigating Democratic Legitimacy and Political Pressure

Liam James|--

Latest Education Articles

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Julian Parker|--
Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Frances Wang|--
Recommended Topics